FFFrancesca Fiorentino

Francesca Fiorentino

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Francesca Fiorentino has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • Candida Fonseca

    Centro Hospitalar de Lisboa Ocidental, Heart Failure Unit, Department of Internal Medicine and Day Hospital Hospital São Francisco Xavier Lisbon Portugal

    1 shared publication
  • Daniel Caldeira

    Centro Cardiovascular da Universidade de Lisboa-CCUL (CCUL@RISE), CAML, Faculdade de Medicina, Universidade de Lisboa, Av. Prof. Egas Moniz, 1649-028, Lisboa, Portugal.

    1 shared publication
  • João Costa

    Centro de Estudos de Medicina Baseada na Evidência (CEMBE), Faculdade de Medicina Universidade de Lisboa Lisbon Portugal

    1 shared publication
  • Margarida Borges

    Centro de Estudos de Medicina Baseada na Evidência (CEMBE), Faculdade de Medicina Universidade de Lisboa Lisbon Portugal

    1 shared publication
  • Miguel Gouveia

    Católica Lisbon School of Business and Economics Universidade Católica Portuguesa Lisbon Portugal

    1 shared publication
  • Paula Broeiro-Gonçalves

    Agrupamento de Centros de Saúde Lisboa Central Unidade de Cuidados de Saúde Personalizados dos Olivais Lisbon Portugal

    1 shared publication

Latest Publications

  • Open Access

    The Current and Future Burden of Heart Failure in Portugal

    by Miguel Gouveia, Raquel Ascenção, Francesca Fiorentino, João Costa, Daniel Caldeira, Paula Broeiro-Gonçalves, Candida Fonseca, Margarida Borges

    Aims: Heart failure (HF) is a clinical syndrome with significant social and economic burden. We aimed to estimate the burden of HF in mainland Portugal over a 22-year time horizon, between 2014 and 2036. Methods and results: Heart failure burden was measured in disability-adjusted life years (DALYs), resulting from the sum of years of life lost (YLL) due to premature death and years lost due to disability (YLD). YLL were estimated based on the Portuguese mortality rates reported by the European Detailed Mortality Database. For YLD, disease duration and the overall incidence were estimated using an epidemiological model developed by the World Health Organization (DISMOD II). Disability weights were retrieved from published literature. The impact of ageing was estimated with a shift-share analysis using official demographic projections. In 2014, 4688 deaths were attributed to HF, corresponding to 4.7% of the total deaths in mainland Portugal. DALYs totalled 21 162, 53.9% due to premature death (YLL: 11 398) and 46.1% due to disability (YLD: 9765). Considering only population ageing over a 22-year horizon, the deaths and burden of HF are expected to increase by 73.0% and 27.9%, respectively, reaching 8112 deaths and 27 059 DALYs lost due to HF in 2036. DALY's growth is mainly driven by the increase of YLL, whose contribution to overall burden will increase to 62.0%. Conclusions: Heart failure is an emerging and growing health problem where significant health gains may be obtained. The projected significant increase of HF burden highlights the need to set HF as a priority for healthcare system.